BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 31, 2026
Home » Authors » Douglas Merrill

Douglas Merrill

Articles

ARTICLES

Longtime U.S. Investor Adds Perspective To GLSV Venture

May 14, 2003
By Douglas Merrill
MUNICH, Germany - Is this the worst bear market he's ever seen in biotechnology? (BioWorld International)
Read More

Axaron Cutback To Focus On Stroke Reflects German Sector

May 14, 2003
By Douglas Merrill

Sloning Raises EUR4.3M In Second Round For DNA Cloning Program

May 7, 2003
By Douglas Merrill

Sloning Raises EUR4.3M In Second Round For DNA Cloning Program

May 7, 2003
By Douglas Merrill

Gamma Capital Bucks Austrian Trend, Closes New Venture Round

April 23, 2003
By Douglas Merrill

Gamma Capital Bucks Austrian Trend, Closes New Venture Round

April 23, 2003
By Douglas Merrill

EBML Targets Young Companies In Europe With New EUR25M Fund

April 9, 2003
By Douglas Merrill

Epigenomics Raises EUR21M To Fund Work In DNA Methylation

April 9, 2003
By Douglas Merrill

Serono Signs On Graffinity As Partner For Drug Development

April 9, 2003
By Douglas Merrill
Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International)
Read More

Serono Signs On Graffinity As Partner For Drug Development

April 9, 2003
By Douglas Merrill
Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International)
Read More
View All Articles by Douglas Merrill

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 30, 2026.
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing